Assyro AI
FDA 483 Database

FDA Form 483s Issued in 2023

Every published Form FDA 483 issued in 2023, drawn from the FDA OII FOIA Electronic Reading Room. Drill into any month, or open a record to see the firm, FEI number, establishment type, and location.

97

Published 483s in 2023

12

Months with records

Browse 2023 by month

Most recent Form 483s in 2023

Showing 25 of 97 — open a month above for the full list.

Fujian Genohope Biotech LtdFDA
FEI
3025263427
Issued
Jun 2, 2023
Establishment
Sterile Drug Manufacturer
Location
China
BlendHouse LLCFDA
FEI
3015728839
Issued
Feb 17, 2023
Establishment
Manufacturer
Location
Pennsylvania, United States
Sanofi S.p.A.FDA
FEI
3002807108
Issued
May 22, 2023
Establishment
Drug Manufacturer
Location
Italy
Laboratorios Farmaceuticos Rovi S. A.FDA
FEI
3010705046
Issued
May 19, 2023
Establishment
Sterile Drug Manufacturer
Location
Spain
Suzhou Suncadia Biopharmaceutical CO., Ltd.FDA
FEI
3015786877
Issued
Dec 14, 2023
Establishment
Drug Substance Intermediate Manufacturer
Location
China
Eli Lilly and CompanyFDA
FEI
1819470
Issued
Oct 6, 2023
Establishment
Drug Manufacturer
Location
United States
Oishi Koseido Co., Ltd.FDA
FEI
3010166685
Issued
Sep 1, 2023
Establishment
Finished Pharmaceutical Manufacturer
Location
Japan
Daizo CorporationFDA
FEI
3008470621
Issued
Nov 6, 2023
Establishment
OTC Drug Manufacturer
Location
Japan
Wuxi Biologics Co., Ltd.FDA
FEI
3010606982
Issued
May 9, 2023
Establishment
Active Pharmaceutical Ingredient Manufacturer
Location
China
Dr. Reddy's Laboratories Ltd., BiologicsFDA
FEI
3014250111
Issued
Oct 12, 2023
Establishment
Active Pharmaceutical Ingredient & Finished Dosage Manufacturer
Location
India
Rovi Pharma Industrial Services S.A.FDA
FEI
3016688535
Issued
Sep 22, 2023
Establishment
Finished Pharmaceutical Manufacturer
Location
Spain
Zhejiang Peptides Biotech Co, Ltd.FDA
FEI
3015685285
Issued
Sep 7, 2023
Establishment
Active Pharmaceutical Ingredient Manufacturer
Location
China
Amman Pharmaceutical IndustriesFDA
FEI
3013501887
Issued
Aug 15, 2023
Establishment
Finished Pharmaceutical Manufacturer
Location
Jordan
Fresenius Kabi Oncology LimitedFDA
FEI
3006210232
Issued
Oct 10, 2023
Establishment
Finished Pharmaceutical Manufacturer
Location
India
Patheon Italia S.p.A.FDA
FEI
3003065803
Issued
May 26, 2023
Establishment
Finished Pharmaceutical Manufacturer
Location
Italy
Apicore Pharmaceuticals Private Ltd.FDA
FEI
3006767695
Issued
May 5, 2023
Establishment
Human Drug Manufacturer
Location
India
Regeneron Ireland Designated Activity CompanyFDA
FEI
3011684330
Issued
Mar 14, 2023
Establishment
Active Pharmaceutical Ingredient Manufacturer
Location
Ireland
Takeda Pharmaceutical Company, LimitedFDA
FEI
3004664162
Issued
Nov 6, 2023
Establishment
Human Drug Manufacturer
Location
Japan
Astellas Pharma Inc.FDA
FEI
3002809620
Issued
Oct 27, 2023
Establishment
Finished Pharmaceutical Manufacturer
Location
Japan
Jubilant HollisterStier General PartnershipFDA
FEI
3001623073
Issued
Feb 28, 2023
Establishment
Finished Pharmaceutical Manufacturer
Location
Canada
Nanchang Anobri Pharmaceutical Co., Ltd.FDA
FEI
3023765884
Issued
Nov 21, 2023
Establishment
Finished Pharmaceutical Manufacturer
Location
China
Aqualex Co., Ltd.FDA
FEI
3010683345
Issued
Oct 20, 2023
Establishment
Finished Pharmaceutical Manufacturer
Location
Republic of Korea
TERUMO YAMAGUCHI CORPORATIONFDA
FEI
3013611763
Issued
Mar 30, 2023
Establishment
Finished Pharmaceutical Manufacturer
Location
Japan
Samsung Bioepis Co., Ltd.FDA
FEI
3010031951
Issued
Sep 15, 2023
Establishment
Sponsor
Location
Republic of Korea
Eisai CompanyFDA
FEI
3004967045
Issued
Oct 27, 2023
Establishment
Finished Pharmaceutical Manufacturer
Location
Japan

Other years

Back to the FDA 483 Database